April 21, 2026
The hospital services market is predicted to grow from USD 13.19 trillion in 2026 to USD 28.99 trillion by 203...
Read MoreMarch 04, 2026
The simulators market size is forecast to increase from USD 14.71 billion in 2026 to USD 27.59 billion by 2035...
Read MoreJanuary 19, 2026
The anti-aging market size is forecast to grow from USD 84.41 billion in 2026 to USD 137.13 billion by 2035, g...
Read MoreJanuary 19, 2026
The U.S. digital health market size is forecast to increase from USD 98.69 billion in 2026 to USD 266.5 billio...
Read MoreApril 21, 2026
Based on market forecasts, the monoclonal antibodies therapeutics sector will expand from USD 265.17 billion in 2024 to USD 1057.91 billion by 2034, experiencing a CAGR of 14.84%. In 2024, North America led the monoclonal antibody therapeutics market, with human mABs and cancer applications holding the largest shares. Asia Pacific is set for the fa...
April 21, 2026
Based on market forecasts, the pharma 4.0 sector will expand from USD 12.76 billion in 2024 to USD 72.58 billion by 2034, experiencing a CAGR of 19%. In 2024, North America led the Pharma 4.0 market, while Asia-Pacific is set for the fastest growth. Software dominated by type, but services will rise. AI & ML led in technology, with blockchain g...
April 21, 2026
According to market projections, the isotope sector is expected to grow from USD 6.09 billion in 2024 to USD 14.2 billion by 2034, reflecting a CAGR of 8.84%. In 2024, North America led the global isotope market, while Asia-Pacific is set for the fastest growth. Radioisotopes dominated, but stable isotopes are expected to rise. Diagnostics held the...
April 21, 2026
Market insights predict the global progesterone industry will increase from USD 1.52 billion in 2024 to USD 5.05 billion by 2034, achieving a CAGR of 12.74%. In 2024, North America led the progesterone market, while Asia Pacific is set for the fastest growth. Natural formulations held the largest share, but synthetic ones will grow quickest. Inject...
April 21, 2026
According to market projections, the global ectopic pregnancy market, valued at USD 9.03 billion in 2024, is anticipated to reach USD 16.09 billion by 2034, growing at a CAGR of 5.94% over the next decade. In 2024, North America led the ectopic pregnancy market, with tubal ectopic cases and folic acid analogue treatments dominating. Retail pharmaci...
April 21, 2026
According to market projections, the hormonal replacement therapy sector is expected to grow from USD 24.26 billion in 2024 to USD 46.32 billion by 2034, reflecting a CAGR of 6.68%. In 2024, North America led the hormonal replacement therapy market with a 40% share, while Asia Pacific is set for the fastest growth. Estrogen and progesterone therapy...
April 21, 2026
Based on market forecasts, the cutaneous squamous cell carcinoma treatment sector will expand from USD 13.69 billion in 2024 to USD 27.54 billion by 2034, experiencing a CAGR of 7.24%. In 2024, North America led the cutaneous squamous cell carcinoma treatment market, while Asia-Pacific is set for the fastest growth. Non-surgical treatments dominate...
April 21, 2026
Projections indicate that, patient monitoring devices industry is projected to rise from USD 63.94 billion in 2025 to USD 134.63 billion by 2035, reflecting a CAGR of 7.73% over the next decade. North America led the global patient monitoring devices market, while Asia-Pacific is set for the fastest growth. Multi-parameter monitoring devices domina...
April 21, 2026
According to market projections, the U.S. patient monitoring devices sector is expected to grow from USD 21.4 billion in 2024 to USD 44.68 billion by 2034, reflecting a CAGR of 7.64%. In 2024, multi-parameter monitoring devices led the market, while cardiac monitoring devices are set for strong growth. Hospitals held the largest market share, but h...
April 21, 2026
Market insights predict the global robotic surgery industry will increase from USD 13.79 billion in 2025 to USD 63.73 billion by 2035, achieving a CAGR of 16.54%. In 2024, North America led the market. The increasing number of surgical procedures conducted globally, primarily driven by the rise in chronic diseases and a growing preference for minim...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com